Ecraid contributed to a dialogue on antimicrobial resistance and novel antibiotics targeting bacterial priority pathogens, supporting analyses and background papers for WHO guidance on evidence generation.
Published
Signal category
Research & Knowledge
Quote
“Ecraid is pleased to contribute to this important work by supporting this dialogue and helping to develop the analyses and background papers that will help inform future WHO guidance on evidence generation for #novelantibiotics targeting bacterial priority #pathogens”
— Ecraid team
Company
Ecraid
Ecraid advances clinical research in the field of infectious diseases.
- Industry
- Hospitals and Health Care
- Location
- Utrecht, NL
- Company size
- 87 employees
The European Clinical Research Alliance on Infectious Diseases (Ecraid) is a not-for profit foundation that advances clinical research in the field of infectious diseases by establishing a long-term, financially self-sustainable, clinical research network in Europe. Headquartered in Utrecht, the Netherlands, Ecraid is the first network of its kind in Europe to offer a single point of access to a pan-European clinical research network for infectious diseases, spanning 1,200 clinical sites and 1,000 laboratories across 42 countries. For more information, please visit www.ecraid.eu.
Founded 2021